Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Secukinumab Open Label Roll-over Extension Protocol |
Autoimmunity, Inflammation | Phase4 | Brazil Bulgaria China Colombia Czechia Guatemala Italy Poland Russia Spain Switzerland United States View all |
NCT04638647 |
Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA-positive Prostate Cancer, With/Without Prior 177Lu-PSMA RLT |
Prostate Cancer | Phase1, Phase2 | Australia Canada France United States View all |
NCT05983198 |
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis |
Multiple Sclerosis | Phase4 | Taiwan | NCT04480853 |
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up |
Chronic Spontaneous Urticaria | Phase3 | Argentina Canada China Germany Hong Kong Italy Japan Malaysia Netherlands Poland Singapore South Africa Spain Thailand Turkey (Türkiye) United Kingdom United States View all |
NCT05677451 |
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis |
Lupus Nephritis | Phase3 | Argentina Brazil Canada Colombia Estonia France Germany Guatemala Hong Kong Hungary India Italy Lithuania Malaysia Mexico Romania Singapore South Korea Spain Taiwan United Kingdom United States View all |
NCT05126277 |